Primary Category:
Treatment Protocols
Disease Category:
Endometrial, Gynecologic
Status:
New, Open
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVB or Recurrent Endometrial Cancer
Eligible for screening study DCP 001
NCT#03914612
